Drug Research

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has announced approximately $1.7 million in planned project activities through the Institute's Global Health Fund (GHF) Project Call 6.1G for three new projects focused on the development of in vitro...

AtomVie Global Radiopharma has signed a lease agreement with Panattoni Development Company in Hamilton, Ontario, Canada, for its new state-of-the-art facility. AtomVie's new facility will be dedicated to high volume clinical and commercial GMP manufacturing and worldwide distribution of...

Novo Nordisk plans to expand its R&D presence in the greater Boston area, creating one of its largest R&D hubs outside of Denmark. The new hub, which will leverage the company’s existing presence in Lexington, Cambridge and Watertown, MA,...

Actylis, a global manufacturer of raw materials and performance ingredients for the life sciences and specialty chemicals markets, has opened a new 30,000 square foot cGMP facility in Eugene, OR. The multi-million dollar construction commenced in February of 2021...

AtomVie Global Radiopharma has signed a lease agreement with Panattoni Development Company in Hamilton, Ontario, Canada, for its new state-of-the-art facility. AtomVie's new facility will be dedicated to high volume clinical and commercial GMP manufacturing and worldwide distribution of...

Radiopharm Theranostics , a developer of radiopharmaceutical products for both diagnostic and therapeutic uses, is pleased to announce that through its wholly owned subsidiary, Radiopharm Theranostics (USA) Inc., it has entered into a binding agreement to acquire Pharma15 Corporation...

Greenphire, the global leader when it comes to financial lifecycle management for clinical trials, recently announced the appointment of its new Chief Financial Officer, Owen Newman. Owen, who is adept in operations and financial management, comes with a rich experience of 25...